• Solutions are customized for payers, providers, pharmaceutical companies, and government agencies

CARMEL, Ind., Jan. 9, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, today announced the expansion of its cybersecurity offerings in support of its healthcare customers.

Cybersecurity is essential in healthcare because of the sensitive nature of the patient data being handled and the negative effects cyber-attacks can have on millions of Americans. According to a 2020 HHS Report on cybersecurity, 560 health organizations were impacted by ransomware attacks, and approximately one million healthcare records were breached monthly.

"We have read the news and heard from our customers repeatedly about their data protection concerns and have invested significantly in the development and maintenance of advanced security protocols, encryption technologies, and monitoring solutions," said Sandeep Allam, Executive Chairman and President, Syra Health. 

Beyond Syra Health's existing Cybersecurity solutions, which include comprehensive risk assessments and proactive monitoring, the Company is now offering government agencies additional services such as:

• Threat intelligence and prevention plans
• Data protection and privacy compliance services
• Policy development and implementation for healthcare cybersecurity
• Cybersecurity audits and assessments for healthcare facilities
• Secure mobile and telehealth solutions

Malware and Ransomware attacks can be particularly devastating for payers when personal information can then be used for malicious activities such as healthcare insurance fraud.

Syra Health's enhanced solutions for payers include:

• Proactive risk management for insurance including real-time monitoring and analysis
• Continuous fraud detection and prevention services, including collaboration with law enforcement
• Secure and transparent claims processing and payment systems
• Data encryption and protection for sensitive payer information
• Compliance monitoring for payer information

For biopharmaceutical companies where intellectual property protection is paramount, Syra Health is offering its customers:

• Intellectual property protection for drug development
• Secure clinical trial data management and storage
• Supply chain security and anti-counterfeiting measures
• Regulatory compliance assistance for the drug approval process
• R&D data protection and cyber threat monitoring

For healthcare providers responsible for upholding HIPAA (Health Insurance Portability and Accountability Act) and preventing sensitive patient health information from being disclosed, Syra Health now offers:

• Expertise in HITECH (Health Information Technology for Economic and Clinical Health), for the adoption and meaningful use of electronic health records (EHRs)
• SOC2 compliance
• Automation and internal auditing of processes and compliance tasks
• Medical device security and vulnerability assessments
• Training and education on cyber hygiene for healthcare staff
• Electronic Health Record security and privacy solutions
• Secure patient data management and sharing
• Networking security for hospital systems and infrastructure

"At Syra Health, our solutions are focused on prevention, affordability, and accessibility, said Dr. Deepika Vuppalanchi, CEO, Syra Health. "This same approach applies to our expanded cybersecurity offerings. We are doing all that we can to support our partners in healthcare by preventing cyberattacks from occurring."

ABOUT SYRA HEALTH

Syra Health is a healthcare technology company addressing some of healthcare's most significant challenges in areas such as behavioral and mental health, digital health, and population health, by providing innovative services and technology solutions. Syra Health's products and services are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and the government. For more information, please visit www.syrahealth.com.

Forward-Looking Statements

Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute"forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors outlined in our registration statement on Form S-1 and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

For more information, please contact:

For Media Inquiries:
Christine Drury
Communications & Marketing Director
Syra Health
463-345-5180
This email address is being protected from spambots. You need JavaScript enabled to view it.

For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
This email address is being protected from spambots. You need JavaScript enabled to view it.